UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use

PloS one, 2009-06, Vol.4 (6), p.e6079-e6079

2009

Link zum Volltext

Verfügbarkeit prüfen

Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes

The Journal of infectious diseases, 2009-03, Vol.199 (5), p.693-701

2009

Link zum Volltext

Verfügbarkeit prüfen

HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China

PloS one, 2016-02, Vol.11 (2), p.e0149215-e0149215

2016

Link zum Volltext

Verfügbarkeit prüfen

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

JAMA : the journal of the American Medical Association, 2011-04, Vol.305 (13), p.1327

2011

Link zum Volltext

Verfügbarkeit prüfen

Fostemsavir: a first-in-class HIV-1 attachment inhibitor

Current opinion in HIV & AIDS, 2022-01, Vol.17 (1), p.32

2022

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology, Seasonality, and Predictors of Outcome of AIDS-Associated Penicillium marneffei Infection in Ho Chi Minh City, Viet Nam

Clinical infectious diseases, 2011-04, Vol.52 (7), p.945-952

2011

Link zum Volltext

Verfügbarkeit prüfen

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

AIDS (London), 2012-01, Vol.26 (2), p.185-192

2012

Link zum Volltext

Verfügbarkeit prüfen

Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations

PloS one, 2012-07, Vol.7 (7), p.e40514-e40514

2012

Link zum Volltext

Verfügbarkeit prüfen

Deep Sequencing of HIV: Clinical and Research Applications

Annual review of genomics and human genetics, 2014-01, Vol.15 (1), p.295-325

2014

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China

PloS one, 2014-06, Vol.9 (6), p.e98740-e98740

2014

Link zum Volltext

Verfügbarkeit prüfen

Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (START) study

HIV medicine, 2024-02, Vol.25 (2), p.212-222

2024

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study

PloS one, 2010-06, Vol.5 (6), p.e10952-e10952

2010

Link zum Volltext

Verfügbarkeit prüfen

Impact of Minority Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Resistance Genotype After Virologic Failure

The Journal of infectious diseases, 2013-03, Vol.207 (6), p.893-897

2013

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent?

PloS one, 2020-08, Vol.15 (8), p.e0237127-e0237127

2020

Link zum Volltext

Verfügbarkeit prüfen

Transmission of HIV drug resistance: lessons from sensitive screening assays

Current opinion in infectious diseases, 2015-02, Vol.28 (1), p.23-30

2015

Link zum Volltext

Verfügbarkeit prüfen

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

The Lancet (British edition), 2006-12, Vol.368 (9553), p.2125-2135

2006

Link zum Volltext

Verfügbarkeit prüfen

Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies

AIDS (London), 2007-07, Vol.21 (12), p.1579-1589

2007

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C protease and polymerase inhibitors in development

AIDS patient care and STDs, 2008-06, Vol.22 (6), p.449

2008

Link zum Volltext

Verfügbarkeit prüfen

Low-frequency NNRTI-resistant HIV-1 variants and relationship to mutational load in antiretroviral-naïve subjects

Viruses, 2014-09, Vol.6 (9), p.3428-3437

2014

Link zum Volltext

Verfügbarkeit prüfen

ANÁLISE DE SUBGRUPO DOS RESULTADOS DE EFICÁCIA E SEGURANÇA DA SEMANA 96 AVALIANDO O FOSTEMSAVIR EM PARTICIPANTES INFECTADOS POR HIV‐1 EXTENSAMENTE EXPERIMENTADOS AO TRATAMENTO NO ESTUDO DE FASE 3 BRIGHTE: RESULTADOS DA COORTE RANDOMIZADA

The Brazilian journal of infectious diseases, 2021-01, Vol.25, p.101055, Article 101055

2021

Link zum Volltext

Verfügbarkeit prüfen

Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing

PloS one, 2012-02, Vol.7 (2), p.e30118

2012

Link zum Volltext

Verfügbarkeit prüfen

Use of new technologies to detect and understand HIV drug resistance

Retrovirology, 2010-05, Vol.7 (S1), p.I19-I19, Article I19

Kozal, Michael J

2010

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV–Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening before Initiation of Antiretroviral Therapy

Clinical infectious diseases, 2005-02, Vol.40 (3), p.468-474

2005

Link zum Volltext

Verfügbarkeit prüfen

The hunt for HIV-1 integrase inhibitors

AIDS patient care and STDs, 2006-07, Vol.20 (7), p.489

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(89)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use

Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment–Naive Patients Significantly Impact Treatment Outcomes

HIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, China

Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis

Fostemsavir: a first-in-class HIV-1 attachment inhibitor

Epidemiology, Seasonality, and Predictors of Outcome of AIDS-Associated Penicillium marneffei Infection in Ho Chi Minh City, Viet Nam

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

Development of elvitegravir resistance and linkage of integrase inhibitor mutations with protease and reverse transcriptase resistance mutations

Deep Sequencing of HIV: Clinical and Research Applications

Prevalence of WHO transmitted drug resistance mutations by deep sequencing in antiretroviral-naïve subjects in Hunan Province, China

Rate of response to initial antiretroviral therapy according to level of pre‐existing HIV‐1 drug resistance detected by next‐generation sequencing in the strategic timing of antiretroviral treatment (START) study

Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals

Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE study

Impact of Minority Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations on Resistance Genotype After Virologic Failure

SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent?

Transmission of HIV drug resistance: lessons from sensitive screening assays

A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial

Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies

Hepatitis C protease and polymerase inhibitors in development

Low-frequency NNRTI-resistant HIV-1 variants and relationship to mutational load in antiretroviral-naïve subjects

ANÁLISE DE SUBGRUPO DOS RESULTADOS DE EFICÁCIA E SEGURANÇA DA SEMANA 96 AVALIANDO O FOSTEMSAVIR EM PARTICIPANTES INFECTADOS POR HIV‐1 EXTENSAMENTE EXPERIMENTADOS AO TRATAMENTO NO ESTUDO DE FASE 3 BRIGHTE: RESULTADOS DA COORTE RANDOMIZADA

Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencing

Use of new technologies to detect and understand HIV drug resistance

Prevalence of Antiretroviral Drug Resistance Mutations in Chronically HIV–Infected, Treatment-Naive Patients: Implications for Routine Resistance Screening before Initiation of Antiretroviral Therapy

The hunt for HIV-1 integrase inhibitors

Suchergebnisse filtern